Together, these results indicate that Lgr5+ liver stem cells exist in human liver fibrosis tissues, and that the therapeutic approach for liver fibrosis using rHGF combined with rRspo1 injection to induce more Lgr5+ liver stem cells may also work in humans. This evidence concerns the gene LGR5 and Hepatic fibrosis.